Ketamine: A new chapter for clinical psychopharmacology?

Abstract

Get full access to this article

View all access options for this article.

References

Borentain

Desai

, et al. (2023) Commentary on Cochrane Review: ‘Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder’. J Psychopharmacol. Epub ahead of print 11 October 2023. DOI: 10.1177/02698811221123046.

Burrows

Kotoula

Dipasquale

Stringaris

, et al. (2023) Ketamine-induced changes in resting state connectivity, 2h after the drug administration in patients with remitted depression. J Psychopharmacol. Online ahead of print 25 July 2023. DOI: 10.1177/02698811231189432.

Chisamore

Danayan

Rodrigues

, et al. (2023) Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth. J Psychopharmacol. Epub ahead of print 16 May 2023. DOI: 10.1177/02698811231171531.

Dean

Hurducas

Hawton

, et al. (2021) Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Cochrane Database Syst Rev 9: CD011612.

Hartland

Mahdavi

Jelen

, et al. (2023) A transdiagnostic systematic review and meta-analysis of ketamine's anxiolytic effects. J Psychopharmacol. Epub ahead of print 2 April 2023. DOI: 10.1177/02698811231161627.

Husain

Strawbridge

Stokes

, et al. (2017) Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis. J Psychopharmacol 31: 1137–1148.

James

Wakefield

(2023) The safety of repeated ketamine dosing in paediatrics: A systematic review. J Psychopharmacol. Epub ahead of print 2 June 2023. DOI: 10.1177/02698811231177240.

Lin

, et al. (2023) Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion. J Psychopharmacol. Epub ahead of print 18 June 2023. DOI: 10.1177/02698811231182107.

Marguilho

Figueiredo

Castro-Rodrigues

(2023) A unified model of ketamine’s dissociative and psychedelic properties. J Psychopharmacol 37: 14–32.

10.

Munch

Amat-Foraster

Agerskov

, et al. (2023) Sub-anesthetic doses of ketamine increase single cell entrainment in the rat auditory cortex during auditory steady-state response. J Psychopharmacol. Epub ahead of print 11 May 2023. DOI: 10.1177/02698811231164231.

11.

Palamar

Fitzgerald

Grundy

, et al. (2023) Characteristics of poisonings involving ketamine in the United States, 2019–2021. J Psychopharmacol. Epub ahead of print 7 December 2023. DOI: 10.1177/02698811221140006.

12.

Speers

Sissons

Cleland

, et al. (2023) Hippocampal phase precession is preserved under ketamine, but the range of precession across a theta cycle is reduced. J Psychopharmacol. Online ahead of print 29 July 2023. DOI: 10.1177/02698811231187339